Skip to main content

Table 2 Response to GD by histological subtypes

From: Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients

 

CR

PR

SD

PD

NE

RR (%)

All

2

11

55

55

11

9.7

Leiomyosarcoma

0

5

19

12

2

13.2

Undifferentiated pleomorphic sarcoma

1

2

11

4

2

15.0

Osteosarcoma

0

0

7

8

2

0

Liposarcoma

0

0

2

5

2

0

Synovial sarcoma

0

0

3

4

0

0

Malignant peripheral nerve sheath tumor

0

1

0

5

1

14.3

Angiosarcoma

0

1

1

1

1

25.0

Ewing sarcoma

0

1

1

2

0

25.0

Epithelioid sarcoma

0

0

1

3

0

0

Rhabdomyosarcoma

0

0

2

1

0

0

Others

1

1

8

10

1

9.5

  1. CR complete response, PR partial response, SD stable disease, PD progressive disease, NE not evaluable, RR response rate